Ambulatory home oxygen: What is the evidence for benefit, and who does it help?

Respiratory Care

Volumn 58, Issue 1, 2013, Pages 48-62

  Criner, Gerard J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory oxygen; COPD; Emphysema

Indexed keywords

AMBULATORY CARE; BREATHING EXERCISE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DYSPNEA; EVIDENCE BASED MEDICINE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEMATOCRIT; HOME OXYGEN THERAPY; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LONG TERM CARE; LUNG CANCER; LUNG EMPHYSEMA; LUNG HEMODYNAMICS; MORTALITY; OUTCOME ASSESSMENT; OXYGEN DESATURATION; OXYGEN SUPPLY; PULMONARY HYPERTENSION; QUALITY OF LIFE;

ANOXIA; COGNITION DISORDERS; DYSPNEA; EXERCISE TOLERANCE; HEART FAILURE; HEMATOCRIT; HOME CARE SERVICES; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; MOTOR ACTIVITY; NEOPLASMS; OXYGEN; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TIME FACTORS;

EID: 84873646597     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01918     Document Type: Conference Paper

References (93)

1. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(4): 892-898.
2. Department of Health and Human Services Office of Inspector General. Medicare and FEHB payment rates for home oxygen equipment. Washington, DC: US Government Printing Office; 2005. Inspector General Publication Number OEI-09-03-00160.
3. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5(4):513-518.
4. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B, Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest 2010;138(1):179-187.
5. Corrado A, Renda T, Bertini S. Long-term oxygen therapy in COPD: evidences and open questions of current indications. Monaldi Arch Chest Dis 2010;73(1):34-43.
6. Make B, Krachman S, Panos RJ, Doherty DE, Stoller JK. Oxygen therapy in advanced COPD: in whom does it work? Semin Respir Crit Care Med 2010;31(3):334-342.
7. Mitchell GS, Baker TL, Nanda SA, Fuller DD, Zabka AG, Hodgeman BA, et al. Invited review: intermittent hypoxia and respiratory plasticity. J Appl Physiol 2001;90(6):2466-2475.
8. Raj U, Shimoda L. Oxygen-dependent signaling in pulmonary vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002; 283(4):L671-L677.
9. Semenza GL. Regulation of metabolism by hypoxia-inducible factor Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 2011;76:347-353.
10. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1(8222):681-686.
11. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93(3):391-398.
12. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999; 14(5):1002-1008.
13. Górecka D, Gorzelak K, Sliwiński P, Tobiasz M, Zieliński J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52(8):674-679.
14. Selinger SR, Kennedy TP, Buescher P, Terry P, Parham W, Gofreed D, et al. Effects of removing oxygen from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987;136(1):85-91.
15. Drummond MB, Blackford AL, Benditt JO, Make BJ, Sciurba FC, McCormack MC, et al. Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest 2008;134(3):497-506.
16. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985;102(1):29-36.
17. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131(4):493-498.
18. Sliwinski P, Hawrylkiewicz I, Gorecka D, Zielinski J. Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146(3):665-669.
19. Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, et al. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax 2003;58(4):289-293.
20. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005;128(3):1201-1208.
21. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
22. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1983; 143(10):1941-1947.
23. Hjalmarsen A, Waterloo K, Dahl A, Jorde R, Viitanen M. Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol 1999;42(1): 27-35.
24. Thakur N, Blanc PD, Julian LJ, Yelin EH, Katz PP, Sidney S, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010;5:263-269.
25. Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H, et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 2004;98(1):66-77.
26. Andersson A, Strom K, Brodin H, Alton M, Boman G, Jakobsson P, et al. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J 1998;12(6): 1284-1289.
27. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996;51(1):44-47.
28. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 2005;25(6):1032-1038.
29. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20(2):306-312.
30. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Longterm oxygen therapy improves health-related quality of life. Respir Med 2004;98(4):285-293.
31. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007;176(4):343-349.
32. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006; 174(4):373-378.
33. Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J 1996;9(12):2584-2589.
34. Garcia-Talavera I, Garcia CH, Macario CC, de Torres JP, Celli BR, Aguirre-Jaime A. Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg. Respir Med 2008;102(7):1026-1032.
35. Owens GR, Rogers RM, Pennock BE, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 1984;310(19):1218-1221.
36. Knower MT, Dunagan DP, Adair NE, Chin R, Jr. Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. Arch Intern Med 2001;161(5):732-736.
37. Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 2001;120(1):88-92.
38. Lewko A, Marshall J, Garrod R. Ambulatory oxygen therpay assessment: a comparative study of incremental shuttle and 6-minute walking tests. Physiotherapy 2007;93:261-266.
39. Kawakami Y, Terai T, Yamamoto H, Murao M. Exercise and oxygen inhalation in relation to prognosis of chronic obstructive pulmonary disease. Chest 1982;81(2):182-188.
40. Tojo N, Ichioka M, Chida M, Miyazato I, Yoshizawa Y, Miyasaka N. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med 2005;44(1):20-25.
41. Takigawa N, Tada A, Soda R, Date H, Yamashita M, Endo S, et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007;101(3):561-567.
42. Vandenbergh E, Clement J, Van de Woestijne KP. Course and prognosis of patients with advanced chronic obstructive pulmonary disease. Evaluation by means of functional indices. Am J Med 1973; 55(6):736-746.
43. Christensen CC, Ryg MS, Edvardsen A, Skjonsberg OH. Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients. Eur Respir J 2004;24(4):580-586.
44. Cotes JE, Gilson JC. Effect of oxygen on exercise ability in chronic respiratory insufficiency; use of portable apparatus. Lancet 1956; 270(6928):872-876.
45. Davidson AC, Leach R, George RJ, Geddes DM. Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax 1988;43(12):965-971.
46. Leggett RJ, Flenley DC. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale. Br Med J 1977;2(6079): 84-86.
47. Bradley BL, Garner AE, Billiu D, Mestas JM, Forman J. Oxygenassisted exercise in chronic obstructive lung disease. The effect on exercise capacity and arterial blood gas tensions. Am Rev Respir Dis 1978;118(2):239-243.
48. Voduc N, Tessier C, Sabri E, Fergusson D, Lavallee L, Aaron SD. Effects of oxygen on exercise duration in chronic obstructive pulmonary disease patients before and after pulmonary rehabilitation. Can Respir J 2010;17(1):e14-e19.
49. Jolly EC, Di Boscio V, Aguirre L, Luna CM, Berensztein S, Gene RJ. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest 2001; 120(2):437-443.
50. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003;168(9):1034-1042.
51. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med 1995;152(5 Pt 1):1616-1619.
52. Liker ES, Karnick A, Lerner L. Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale. A controlled double-blind crossover study. Chest 1975;68(2):236-241.
53. Wadell K, Henriksson-Larsen K, Lundgren R. Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J Rehabil Med 2001;33(5): 200-205.
54. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J 1997;10(6):1278-1284.
55. Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 2011;66(1):32-37.
56. Ram FS, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;(2)(2): CD000238.
57. Swinburn CR, Mould H, Stone TN, Corris PA, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis 1991;143(5 Pt 1):913-915.
58. Morrison DA, Stovall JR. Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest 1992;102(2):542-550.
59. Bye PT, Esau SA, Levy RD, Shiner RJ, Macklem PT, Martin JG, et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 1985; 132(2):236-240.
60. Criner GJ, Celli BR. Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia. J Appl Physiol 1987; 63(1):195-200.
61. Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2004;59(8):668-672.
62. Payen JF, Wuyam B, Levy P, Reutenauer H, Stieglitz P, Paramelle B, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993;147(3): 592-598.
63. Jakobsson P, Jorfeldt L. Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia. Respir Med 1995; 89(7):471-476.
64. Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007;(2):CD005372.
65. Wedzicha JA. Short burst oxygen therapy is helpful? Chron Respir Dis 2004;1(2):101-103.
66. Evans TW, Waterhouse JC, Carter A, Nicholl JF, Howard P. Short burst oxygen treatment for breathlessness in chronic obstructive airways disease. Thorax 1986;41(8):611-615.
67. Killen JW, Corris PA. A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea. Thorax 2000; 55(7):544-546.
68. McKeon JL, Murree-Allen K, Saunders NA. Effects of breathing supplemental oxygen before progressive exercise in patients with chronic obstructive lung disease. Thorax 1988;43(1):53-56.
69. Nandi K, Smith AA, Crawford A, MacRae KD, Garrod R, Seed WA, et al. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2003; 58(8):670-673.
70. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet 1981;1(8226):907-909.
71. Lewis CA, Eaton TE, Young P, Kolbe J. Short-burst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients. Eur Respir J 2003;22(4):584-588.
72. O'Driscoll BR, Neill J, Pulakal S, Turkington PM. A crossover study of short burst oxygen therapy (SBOT) for the relief of exerciseinduced breathlessness in severe COPD. BMC Pulm Med 2011;11: 23.
73. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006;27(4):689-696.
74. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174(7):803-809.
75. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25(1):96-103.
76. Bye PT, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis 1982;126(6):1005-1012.
77. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994;150(6 Pt 1):1616-1622.
78. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000;161(4 Pt 1):1172-1178.
79. Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001;(3)(3): CD002883.
80. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63(Suppl 5):v1-58. Erratum in: Thorax 2008;63(11):1029.
81. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 2011;123(4):e18-e209.
82. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H, CHF-HOT Study Group. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 2006;70(1):1-7.
83. Javaheri S, Ahmed M, Parker TJ, Brown CR. Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999;22(8):1101-1106.
84. Krachman SL, D'Alonzo GE, Berger TJ, Eisen HJ. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999;116(6):1550-1557.
85. Restrick LJ, Davies SW, Noone L, Wedzicha JA. Ambulatory oxygen in chronic heart failure. Lancet 1992;340(8829):1192-1193.
86. Russell SD, Koshkarian GM, Medinger AE, Carson PE, Higginbotham MB. Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure. Am J Cardiol 1999;84(12):1412-1416.
87. Abernethy AP, Currow DC, Frith P, Fazekas B. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliat Med 2005;19(2):168-170.
88. Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(6):CD006429.
89. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE 2nd, Marcello J, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a doubleblind, randomised controlled trial. Lancet 2010;376(9743):784-793.
90. Centers for Medicare and Medicaid Services. Medicare Coverage Database, NCD Chapter 240.2. Available from: http://www.cms. hhs.gov/mcd/index_chapter_list.asp. Accessed December 6, 2012.
91. Arnold E, Bruton A, Donovan-Hall M, Fenwick A, Dibb B, Walker E. Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm Med 2011;11:9.
92. Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, et al. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD 2012;9(1):3-11.
93. National Heart, Lung and Blood Institute. Effectiveness of long-term oxygen therapy in treating people with chronic obstructive pulmonary disease (the Long-term Oxygen Treatment Trial [LOTT]). ClinicalTrials no. NCT00692198 http://clinicaltrials.gov/ct2/show/ NCT00692198. Accessed October 25, 2012.